New Trends in Use of Animal Models in Vaccine Development

Dear Colleagues, 

The use of animal models in distinct areas of medical research offers undeniable benefits and contributes to the fast and effective development of different treatments and diagnostic tools, which has led to remarkable improvements in the global health of humans and animals. Their use in vaccine development is not an exception.

Nowadays, the emergence of new pathogens and disease outbreaks worldwide is a prominent risk. Thus, researchers, health professionals and medical technology need to be constantly informed and updated regarding new tools to avoid and combat this eminent hazard.

We are pleased to invite you to share your work and data on new approaches regarding the use of animal models and comparative medicine in vaccine development. Sharing and globally improving our approaches and methods to combat infectious diseases is undoubtedly crucial if we want to control infectious diseases in multiple species and avoid global One Health consequences.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• Different species of animal models;
• Types of animal models used in vaccine research;
• Animal models in emerging infectious disease research;
• Alternatives to the use of animal models in vaccine development;
• Current strategies and methodologies in the development of vaccines using animal models in both human and veterinary medicine.

We look forward to receiving your contributions.

Dr. Ana Faustino
Prof. Dr. Paula Oliveira
Dr. Ana Cláudia Coelho
Guest Editors

Catarina Jota Baptista
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.